Tokyo, June 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058265) titled 'Therapeutic Effects of Ninjin'yoeito on Fatigue During Treatment for Advanced Prostate Cancer' on June 25.
Study Type:
Observational
Primary Sponsor:
Institute - Dr. Kazuyoshi Nakamura, Department of Urology, Kimitsu Chuo Hospital
Condition:
Condition - Fatigue during treatment for advanced prostate cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the anti-fatigue effect of Ninjin'yoeito in patients with advanced prostate cancer who are receiving chemotherapy with novel antiandrogens such as abiraterone, enzalutamide, apalutamide, docetaxel a...